Chemed Corporation $CHE Stock Bought by Kestra Advisory Services LLC

Kestra Advisory Services LLC raised its holdings in Chemed Corporation (NYSE:CHE – Free Report) by 115.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,273 shares of the company’s stock after acquiring an additional 1,757 shares during the period. Kestra Advisory Services LLC’s holdings in Chemed were worth $1,653,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Richardson Financial Services Inc. lifted its position in Chemed by 5,700.0% during the third quarter. Richardson Financial Services Inc. now owns 58 shares of the company’s stock worth $29,000 after buying an additional 57 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Chemed during the second quarter worth $34,000. Versant Capital Management Inc grew its holdings in Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after buying an additional 75 shares in the last quarter. Keating Financial Advisory Services Inc. purchased a new stake in Chemed in the 2nd quarter valued at $36,000. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock valued at $38,000 after buying an additional 32 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Chemed news, EVP Spencer Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $547.61, for a total value of $547,610.00. Following the completion of the transaction, the executive vice president owned 12,931 shares of the company’s stock, valued at $7,081,144.91. This trade represents a 7.18% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Kevin McNamara sold 2,000 shares of the business’s stock in a transaction on Tuesday, November 3rd. The stock was sold at an average price of $537.90, for a total value of $1,075,800.00. Following the transaction, the chief executive officer directly owned 82,220 shares of the company’s stock, valued at $44,226,138. The trade was a 2.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 10,920 shares of company stock worth $5,770,666. 3.33% of the stock is owned by company insiders.

Chemed Stock Up 0.1%

Shares of NYSE CHE opened at $547.16 on Thursday. The firm has a market cap of $7.12 billion, a price-to-earnings ratio of 26.18, a PEG ratio of 2.08 and a beta of 0.50. The company has a quick ratio of 1.08, a current ratio of 1.11 and a debt-to-equity ratio of 0.27. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $562.24. The business’s 50 day moving average is $518.67 and its two-hundred day moving average is $469.36.

Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $6.75 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.44 by $0.31. Chemed had a return on equity of 35.18% and a net margin of 10.61%. The firm had revenue of $690.94 million for the quarter, compared to the consensus estimate of $685.04 million. During the same quarter in the previous year, the business earned $5.27 EPS. The company’s quarterly revenue was up 10.6% compared to the same quarter last year. Research analysts predict that Chemed Corporation will post 24.05 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Monday, November 16th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, November 16th. Chemed’s dividend payout ratio is presently 13.40%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CHE shares. Bank of America restated a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. UBS Group boosted their target price on shares of Chemed from $650.00 to $675.00 and gave the company a “buy” rating in a report on Thursday, October 29th. Oppenheimer lifted their price target on shares of Chemed from $590.00 to $625.00 and gave the company an “outperform” rating in a research report on Thursday, October 29th. Weiss Ratings upgraded Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Finally, Wall Street Zen upgraded Chemed from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 10th. Three analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, Chemed presently has an average rating of “Hold” and an average price target of $603.00.

Read Our Latest Report on Chemed

About Chemed

(Free Report)

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.